Search our
Current Studies
A Phase III Randomised, Double-blind Trial to Evaluate Efficacy and Safety of Once Daily Empagliflozin 10 mg Compared to Placebo, in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF)
Location(s): Jacksonville (Headquarters)
Condition: Heart Failure
A study of the equivalence in the safety and efficacy profile between MYL-1601D and NovoLog® in patients with T1DM.
Location(s): Jacksonville (Headquarters)
Condition: Diabetes
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk (SCORED)
Location(s): Jacksonville (Headquarters)
Condition: Diabetes, Heart Disease, Kidney Disease
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn’s Disease (CARMEN CD 305)
Location(s):
Condition: Crohn's disease, Gastrointestinal Disease
A Trial to Evaluate the Efficacy and Safety of the Oral sGC stImulator Vericiguat to Improve Physical Functioning in Activities of Daily Living in Patients With Heart Failure and Preserved Ejection Fraction (VITALITY-HFpEF)
Location(s): St. Augustine
Condition: Heart Disease, Heart Failure
The purpose of the study is to collect data about how well U-100 Regular Human Insulin can be used in the V-Go Insulin Delivery Device compared to U-100 Rapid Acting Insulin in the V-Go Insulin Delivery Device. The data collected will be used to see how much subjects’ blood sugar levels change over time after they switch from using U-100 Rapid Acting Insulin to U-100 Regular Human Insulin within their V-Go Insulin Delivery Device.
Location(s): Jacksonville (Headquarters), Macon
Condition: Diabetes
A Phase III Trial to Evaluate the Effect of EMPagliflozin 10 mg Compared With Placebo on ExeRcise Ability and Heart Failure Symptoms, In Patients With Chronic HeArt FaiLure With Reduced Ejection Fraction (HFrEF) (EMPERIAL-reduced)
Location(s): St. Augustine
Condition: Heart Disease, Heart Failure
A Phase III Trial to Evaluate the Effect of EMPagliflozin 10 mg Compared With Placebo on ExeRcise Ability and Heart Failure Symptoms, In Patients With Chronic HeArt FaiLure With Preserved Ejection Fraction (HFpEF) (EMPERIAL – Preserved)
Location(s): St. Augustine
Condition: Heart Disease, Heart Failure
A Phase 2 Study to Evaluate the Safety and Efficacy of IW-1973 in Patients With Type 2 Diabetes With Albuminuria Treated With Renin-Angiotensin System Inhibitors
Location(s): Macon
Condition: Diabetes, Kidney Disease
A Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk
Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Macon
Condition: Diabetes
A multicenter, randomized, open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in subjects with NDD-CKD
Location(s): Jacksonville- LaVilla (Downtown)
Condition: Diabetes, Kidney Disease
A multicenter, randomized, open-label, active-controlled Phase 3 study for the correction of anemia and maintenance of hemoglobin (Hb) in subjects with NDD-CKD
Location(s): Jacksonville- LaVilla (Downtown)
Condition: Diabetes, Kidney Disease
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Location(s): Jacksonville (Headquarters)
Condition: Heart Disease, Heart Failure
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease (FIGARO-DKD)
Location(s): Jacksonville- LaVilla (Downtown), Macon
Condition: Diabetes, Kidney Disease
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
Location(s):
Condition: Gastrointestinal Disease, Ulcerative Colitis
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001) (VICTORIA)
Location(s): Jacksonville (Headquarters)
Condition: Heart Disease, Heart Failure
A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) (CAPACITY-HFpEF)
Location(s): Jacksonville (Headquarters)
Condition: Heart Disease, Heart Failure